Delivery Order SPE2DB22D2007-SPE2DB24FH8EM
Award Date 12/28/23
Potential Completion Date 12/29/23
Potential Value $4.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of 4563816196 Ondansetron ODT 4 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The $16,342.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The ultimate completion date for this order is March 1, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,940.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 6, 2025. The contract has a completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $2,500.32 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 5, 2023 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $16,436.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024 with a completion date of December 10, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $32,239.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $23,040.41 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 13, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,477.96 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 8, 2024 with a completion date of July 9, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $2,940.18 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 26, 2024. The award has an ultimate completion date of April 29, 2024 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant $999,999,999...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $7,245.95 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 20, 2023 and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,234.92 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 5, 2024, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...